Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
10-year high
|
Expensive Star
6948.5000
60.00
(
0.87
%)
NSE
Jul 08, 2025
10:42 AM
New 52W High today
Volume:
250.3K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
04 Feb 2023
10-year high
6948.50
0.87%
Divi's Labs (HOLD): Big miss on revenue and margins
Hold:
Divi's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 3200
Target
BOB Capital Markets Ltd.
Q3 disappoints as revenue/PAT of Rs 17bn/Rs 3bn missed consensus by 12%/38%
Divi's Laboratories Ltd. is trading above all available SMAs
More from Divi's Laboratories Ltd.
More from Suhani Adilabadkar
Recommended
Market opens flat, Titan's revenue grows by 20% YoY in Q1FY26
Trendlyne Marketwatch |
08 Jul 2025, 10:31AM
As IPO fever hits new high, Crizac and three other listings on the horizon
|
07 Jul 2025, 05:34PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022